Connect with us

Technology

Dario Expands Provider-Backed Cardiometabolic Platform with New Women’s Health and Sleep Solutions Aligning with Client Demand

Published

on

New programs, expected to begin revenue contribution Q4 2026, extend Dario’s integrated healthcare platform into two high-impact clinical categories while advancing execution of the Company’s provider-backed care strategy

AI-enabled programs combine digital engagement, human behavioral coaching and clinical care to improve outcomes while expanding Dario’s participation in reimbursement-driven healthcare services

NEW YORK, Aug. 4, 2026 /PRNewswire/ — DarioHealth Corp. (NASDAQ: DRIO) (the “Company”, “DarioHealth” or “Dario”), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced it has further expanded its provider-backed cardiometabolic platform with the launch of Dario Women™ and Dario Sleep™. The two new programs address important drivers of cardiometabolic health through an integrated care experience combining AI-powered engagement, behavioral support and access to licensed healthcare providers.

The new offerings come as demand from large enterprise payers for multi-condition solutions continues to rise, and single point offerings are phased out. While increasing the indications supported by its platform, Dario has further expanded into provider-backed care to broaden participation in reimbursement-driven healthcare services.

Both Dario Women™ and Dario Sleep™ are expected to roll out to the Company’s Fortune 500 and other clients in Fall 2026. Recurring revenue contribution per engaged member per month for the digital health platform is expected to commence in the fourth quarter of 2026, with revenue from the provider-backed care services anticipated at the end of 2026 and into the beginning of 2027. The new programs are expected to expand revenue opportunities across Dario’s existing enterprise customer base by allowing employers and health plans to address additional high-cost clinical needs through the same integrated platform.

“Dario continues to execute on our strategy of integrating provider-backed care throughout our expanding chronic condition platform,” said Erez Raphael, Chief Executive Officer of Dario. “Women’s health and sleep represent significant opportunities to improve cardiometabolic outcomes while expanding the value we deliver to employers, health plans and members. As we continue adding clinical capabilities to our platform, we strengthen our ability to support members throughout their healthcare journey while creating new opportunities to grow revenue through healthcare services that extend beyond digital engagement.” 

Dario Women: Supporting Women’s Cardiometabolic Health

Dario Women, developed in-house and native to Dario’s solution, supports members navigating perimenopause and menopause, life stages frequently associated with weight changes, sleep disruption, metabolic changes and increased cardiometabolic risk, with one in three women developing metabolic syndrome during menopause transition1.

The program combines AI-powered engagement, personalized human-led behavioral coaching and access to licensed healthcare providers in one, connected member experience. Eligible members may receive clinical evaluation for hormone replacement therapy (HRT), when medically appropriate, following a comprehensive clinical assessment conducted in accordance with evidence-based clinical guidelines and applicable regulations.

Dario Sleep: Connecting Sleep Health to Cardiometabolic Care

Dario Sleep addresses obstructive sleep apnea (OSA), a significant contributor to cardiometabolic disease and rising healthcare costs.

Published research has shown that untreated OSA patients incur approximately 2.5× higher annual healthcare costs than individuals without OSA.2 Cardiometabolic patients with OSA also generate approximately 50% higher annual medical costs, representing an average increase of more than $6,185 per member per year.3

The Dario Sleep program enables eligible members to complete a one-night, clinical-grade home sleep test with real-time data transmitted directly to licensed healthcare providers for evaluation. Based on individual clinical needs, providers determine appropriate treatment pathways, which may include positional therapy, oral appliance therapy, CPAP therapy or GLP-1 treatment when clinically appropriate.

“Our goal is to connect members with the right care through one coordinated experience,” said Lara Dodo, Chief Operating Officer of Dario. “By integrating AI-powered engagement, behavioral coaching and provider-backed clinical care within one platform, we help members access appropriate treatment while giving employers and health plans a more comprehensive solution for managing interconnected chronic conditions.”

Members enrolled in Dario Women and Dario Sleep continue their care journey through Dario’s integrated healthcare platform, which combines connected devices, AI-powered insights, personalized coaching and provider-backed clinical care across diabetes, hypertension, weight management, ergonomic posture, behavioral health, women’s health and sleep.

1 Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women’s Health Across the Nation. Arch Intern Med. 2008;168(14):1568-1575. doi:10.1001/archinte.168.14.1568. PMID: 18663170. https://pubmed.ncbi.nlm.nih.gov/18663170/

2 Zappala P, et al. The Global Socioeconomic Burden of Obstructive Sleep Apnea: A Comprehensive Review. Healthcare (Basel). 2025;13(17):2115. https://doi.org/10.3390/healthcare13172115

3 Patel U. Sleep apnea drives average medical costs up 50% for patients with cardio/obesity. Evernorth Research Institute, January 26, 2024. https://www.evernorth.com/articles/sleep-apnea-cardiodiabesity-medical-costs 

About DarioHealth Corp. (Nasdaq: DRIO)

DarioHealth (Nasdaq: DRIO) is an AI-powered healthcare technology company helping health plans, health systems and employers improve health outcomes while lowering the cost of care. The Company’s integrated platform combines connected devices, personalized member engagement, AI-driven insights and provider-backed clinical care to support people living with conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health needs.

Powered by more than 13 billion proprietary longitudinal healthcare data points collected over more than a decade, Dario’s AI platform personalizes care at the individual member level by analyzing biometric, clinical and behavioral data to deliver more timely and effective interventions. By combining engagement, clinical intelligence and care delivery within a single platform, Dario helps customers address multiple chronic conditions through one solution.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. For example, the Company is using forward-looking statements in this press release when it discusses the expected launch and implementation of the programs; the timing of anticipated revenue contribution by the programs; that the new programs are expected to expand revenue opportunities across Dario’s existing enterprise customer base; and the benefits and uses of the Company’s platform and programs. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company’s results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company’s actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company’s filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company’s commercial and regulatory plans for Dario™ as described herein) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contacts

Michael Lipari
SVP Corporate Development
irteam@dariohealth.com
+1-201-785-6310

Rob Halpern
SVP Marketing
irteam@dariohealth.com 

Logo – https://mma.prnewswire.com/media/2866807/6030938/Dario_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/dario-expands-provider-backed-cardiometabolic-platform-with-new-womens-health-and-sleep-solutions-aligning-with-client-demand-302841434.html

SOURCE DarioHealth Corp.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Academic Orthopaedic Consortium Launches POST™, the First National Digital Platform Connecting MedTech, Pharma, and Academic Orthopaedic Departments

Published

on

By

New platform accelerates collaboration in technology evaluation, research, education, and innovation

CARY, N.C., Aug. 4, 2026 /PRNewswire/ — The Academic Orthopaedic Consortium (AOC), the nation’s largest academic orthopaedic community representing 5,000 members, 200 university-based academic orthopaedic departments, and 100 health systems and private practices, today announced the national launch of POST™, the first national digital platform created specifically to connect MedTech and pharmaceutical companies with academic orthopaedic departments.

Developed over three years of collaboration between nationally recognized academic orthopaedic leaders and industry executives, POST represents a significant new layer of infrastructure for academic-industry collaboration. The platform was created to address two of healthcare innovation’s greatest challenges: efficiently connecting companies developing new technologies with the academic medical centers best positioned to evaluate, validate, educate, and responsibly introduce those innovations into clinical practice, while also advancing best practices that help reduce unnecessary delays in technology evaluation and adoption.

Powered by intelligent matching technology, POST enables organizations to create comprehensive profiles and instantly connect with highly relevant collaborators based on clinical expertise, research interests, educational priorities, innovation initiatives, and technology evaluation capabilities—dramatically reducing the time required to identify the right academic or industry partner. By strengthening collaboration between academic medicine and industry, POST also helps create earlier access to emerging technologies, expands opportunities for research and publication, enhances resident and fellow education, and supports the responsible acceleration of innovation into patient care.

The launch follows one of the largest national assessments examining collaboration between academic orthopaedic departments and the medical technology industry. Through surveys and strategic discussions led by the AOC MedTech Advisory Council, academic leaders identified significant barriers slowing innovation. Technology evaluation processes averaged more than 270 days, only 13% of institutions reported evaluation timelines under 90 days, and only 12%believed their current processes efficiently minimized delays. More than 90% identified purchasing and administrative processes as the primary barriers to technology adoption and called for national best practices to improve collaboration.

“POST represents a fundamental shift in how academic medicine and industry discover one another and work together,” said Michael R. Gagnon, MBA, Founder and CEO of the Academic Orthopaedic Consortium. “For decades, companies have struggled to identify the right academic partners, while academic departments have lacked an efficient, standardized way to engage industry. POST changes that by creating the nation’s first digital platform where organizations can quickly identify one another, build trusted relationships, and accelerate innovation with the shared goal of improving patient care.”

POST also serves as the digital foundation for the newly established AOC Technology Evaluation Network, a national collaborative of academic and industry leaders focused on technology evaluation, innovation, and best practices. Forty-six leading academic orthopaedic departments have already identified Technology Evaluation Leaders who, together with leaders from AOC’s participating industry partners, will help advance best practices, establish more efficient evaluation pathways, and strengthen collaboration across academic medicine and industry. The goal is to help reduce unnecessary delays in technology evaluation while increasing opportunities for research, education, publication, and responsible innovation.

The platform was shaped through the work of the AOC MedTech Advisory Council and the leadership of academic and industry experts committed to improving collaboration throughout orthopaedics. Founding industry collaborators helping shape POST include Arthrex, DePuy Synthes, Medacta, MY01, Smith+Nephew, Stryker, and Think Surgical, with additional organizations continuing to join the platform.

“Academic medicine and industry ultimately have a shared goal to improve patient care through responsible innovation,” said Joshua J. Jacobs, MD, Co-Chair of the AOC MedTech Advisory Council. “POST provides a national framework that enables academic institutions and industry to collaborate more effectively, share best practices, strengthen research partnerships, and accelerate the responsible evaluation and adoption of new technologies.”

“Identifying the right academic collaborators and navigating highly variable institutional processes has long been a challenge for the MedTech industry,” said Stuart Simpson, Co-Chair of the AOC MedTech Advisory Council. “POST creates a trusted national gateway that brings together industry and academic medicine in a way that is more transparent, efficient, and scalable than ever before.”

The Academic Orthopaedic Consortium is now inviting academic orthopaedic departments, MedTech companies, and pharmaceutical organizations to establish organizational profiles on POST and participate in this growing national platform for collaboration, technology evaluation, research, education, and innovation.

To learn more or establish an organizational profile, visit POSTMedTech.com.

About the Academic Orthopaedic Consortium

Founded in 2005, the Academic Orthopaedic Consortium (AOC) is the nation’s largest academic orthopaedic community, representing leading university-based academic orthopaedic departments, health systems, private practices, orthopaedic leaders, researchers, faculty, and administrative executives across the country. Through education, leadership development, research, innovation, and strategic collaboration, the AOC works to strengthen academic orthopaedics and improve musculoskeletal patient care.

POST™: POSTMedTech.com

Academic Orthopaedic Consortium: AOC

View original content to download multimedia:https://www.prnewswire.com/news-releases/academic-orthopaedic-consortium-launches-post-the-first-national-digital-platform-connecting-medtech-pharma-and-academic-orthopaedic-departments-302839885.html

SOURCE Academic Orthopaedic Consortium

Continue Reading

Technology

LeBeouf Bros. Towing Completes Enterprise Deployment of OpenTug’s BargeOS Platform, Advancing Digital Operations Across Its Fleet

Published

on

By

SEATTLE, Aug. 4, 2026 /PRNewswire/ — OpenTug, the AI-native platform purpose-built for inland and coastal barge logistics, today announced the successful enterprise deployment of its BargeOS platform at LeBeouf Bros. Towing (LBT), marking an important milestone in the companies’ partnership and the continued digital transformation of inland marine operations.

Following a phased implementation, LeBeouf Bros. Towing has completed deployment of BargeOS across its commercial voyage and dispatch operations, invoice intelligence, performance indicator workflows, and marketing, making LBT the first barge operator to fully implement the platform across its business.

For decades, LeBeouf Bros. Towing has built a reputation for providing safe, reliable transportation of liquid cargoes throughout the inland waterway system. As customer expectations continue to evolve and operational complexity increases, the company sought a modern operating platform capable of connecting commercial voyage planning, fleet operations, financial workflows, and performance reporting without disrupting the expertise and processes that have long defined its business.

Today, LeBeouf uses BargeOS to support commercial voyage management through automated traffic validation, cargo planning, and predictive ETA capabilities while streamlining invoice generation and reconciliation through a centralized operational workflow. The result is greater operational visibility, improved financial accuracy, and faster collaboration across commercial and operations teams.

“LeBeouf has built an exceptional operation through decades of industry expertise,” said Jason Aristides, CEO and Co-Founder of OpenTug. “Our goal has never been to change how experienced operators work. We instead aim to provide better information, reduce manual effort, and connect critical workflows that have traditionally lived in separate systems. Partnering with LeBeouf Towing represents an exciting milestone in the maturation of BargeOS and demonstrates what modern marine operations can actually look like.”

“BargeOS has helped us improve visibility across our operations while simplifying processes that were previously manual, allowing our teams to spend more time focused on serving customers and managing our fleet,” said Mark Bourgeois, Executive Vice President of LeBeouf Bros. Towing.

The partnership reflects a broader shift taking place across inland marine transportation. As shippers demand greater visibility, faster communication, and increased financial accuracy, operators are investing in technologies that improve operational efficiency while supporting the people and processes that keep freight moving safely and reliably.

“Digital transformation in marine transportation isn’t about replacing experience,” Aristides added. “It’s about giving operators better tools to make faster decisions, improve customer service, and build more resilient businesses. We’re proud to be partnering with LeBeouf as they continue leading that evolution.”

About LeBeouf Bros. Towing

LeBeouf Bros. Towing, LLC is a privately held inland tank barge company which specializes in the carriage of crude oil, clean and dirty petroleum products, and chemicals. LeBeouf operates one of the youngest fleets in the industry which is supported by its fully functional shipyard facility, Bourg Dry Dock & Service, located at the company’s headquarters in Bourg, Louisiana. The company also owns Bayou Blue Fleet located at mile marker 49 on the ICWW which it utilizes for both equipment storage and outside fleeting opportunities.

About OpenTug
OpenTug is the company behind BargeOS, an AI-native software platform for marine logistics. BargeOS helps customers improve productivity, increase visibility, and support better margin outcomes by connecting data, automating workflows, and streamlining decision-making across commercial planning, voyage management, invoice intelligence, and performance management. For more information, visit www.opentug.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lebeouf-bros-towing-completes-enterprise-deployment-of-opentugs-bargeos-platform-advancing-digital-operations-across-its-fleet-302841769.html

SOURCE OpenTug

Continue Reading

Technology

U.S. Marketing Hiring Remains Strong in Q2 2026 as Entry-Level Roles Lose Ground and Remote Hiring Retreats

Published

on

By

NEW YORK, Aug. 4, 2026 /PRNewswire/ — Taligence, an executive search firm specializing in senior marketing hires, has once again partnered with Aspen Technology Labs, a global leader in labor market intelligence, to release the Q2 2026 U.S. Marketing Jobs Report. Based on an analysis of more than 86,000 in-house marketing job listings throughout the second quarter of 2026, the report shows that the U.S. marketing job market remained resilient despite a modest slowdown following a peak in hiring activity during April.

Total active marketing job listings continued to edge higher, more employers recruited for marketing talent, and Director-level and above hiring once again outpaced the broader market. At the same time, companies became increasingly selective in where they invested, with entry-level hiring declining further while demand remained concentrated in commercially focused disciplines such as Growth Marketing, Partner & Channel Marketing, and Brand Marketing.

One notable shift during the quarter was the reversal in remote hiring. After reaching a high in early March, the share of fully remote marketing roles declined steadily through the remainder of the quarter, suggesting that many employers have settled into more permanent hybrid or in-office working models. Median advertised salaries continued to rise during the quarter. However, part of this increase reflects the growing concentration of senior-level hiring, alongside genuine wage growth within marketing roles.

Note: This report covers full-time, in-house marketing positions only.

For the full report, visit:

https://www.taligence.com/job-reports/u-s-marketing-jobs-report-q2-2026

Key Findings from the Q2 2026 U.S. Marketing Jobs Report

1. Hiring Remains Resilient

Total active marketing job listings: 86,628 (+0.4% QoQ)New marketing job postings: 53,961 (-5.1% QoQ)Employers posting marketing jobs: 24,042 (+2.3% QoQ)Live job listings at quarter-end: 36,086 (+7.1% YoY)

2. Senior Marketing Hiring Continues to Outperform

Total senior marketing roles (Director-level and above): 11,659 (+4.5% QoQ)New senior job postings: 7,293 (+2.9% QoQ)Senior roles at quarter-end: 5,082 (+17.3% YoY)

3. Hiring Becomes More Selective

Entry-level hiring declined 4.0% YoY and 16.4% QoQDirector-level and above hiring significantly outpaced all other levelsCompanies continued shifting investment toward experienced marketing talent

4. Median Advertised Salaries Continue to Rise

Median advertised salary: $95,004 (+11.8% YoY), reflecting both higher advertised pay and a continued shift toward more senior hiring.Salary transparency remained high at 55.6% of job listingsField Marketing recorded the strongest salary growth among all disciplines

5. Remote Hiring Retreats

Remote marketing roles accounted for 13.6% of all in-house marketing job listingsRemote hiring declined steadily after reaching a peak in early MarchThe trend points to continued normalization of hybrid and in-office working models

6. Marketing Discipline and Geographic Trends Continue to Evolve

Partner & Channel Marketing, Growth Marketing, Brand Marketing, and Content Marketing recorded the strongest hiring growthProduct Marketing remained the highest-paid marketing disciplineNorth Carolina entered the nation’s top ten marketing hiring states for the first time, while San Francisco recorded the strongest hiring growth among major U.S. cities

“The market isn’t pulling back on marketing investment, it’s becoming much more selective about where that investment goes,” said Michael Wright, CEO of Taligence. “The strongest demand continues to be for marketers who can directly influence growth, partnerships, and brand performance. At the same time, the decline in entry-level hiring raises an important long-term question about how companies will develop the next generation of marketing leaders.”

“Marketing continues to outperform the broader U.S. labor market. Active in-house marketing listings ended Q2 up 7.1% year-over-year, roughly double the 3.7% growth we’re seeing across U.S. job postings overall,” said Michael Woodrow, President of Aspen Technology Labs. “But that growth is not evenly distributed. Director-level and above roles are up 17.3% year-over-year, versus under 6% across all other levels combined, while entry-level listings actually declined. Employers are still hiring marketers. They’re just hiring more experienced ones.”

About Taligence LLC

Taligence is an executive search and talent intelligence firm specializing in senior marketing leadership hires. Through proprietary research and data-driven insights, Taligence helps companies and candidates navigate an increasingly complex talent market. Learn more at www.taligence.com.

About Aspen Technology Labs, Inc.

Aspen Technology Labs is a global leader in web data management services and labor market intelligence. Its JobMarketPulse platform powers real-time hiring insights for organizations worldwide. Learn more at www.AspenTechLabs.com.

Media Contacts:

Taligence LLC
Melody Liu
melody@taligence.com

Aspen Technology Labs, Inc.
Lana Shumyn
lana.s@aspentechlabs.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/us-marketing-hiring-remains-strong-in-q2-2026-as-entry-level-roles-lose-ground-and-remote-hiring-retreats-302842391.html

SOURCE Taligence LLC

Continue Reading

Trending